UA109420C2 - PHARMACEUTICAL COMPOSITION INCLUDING GLP-1 AGONIST, INSULIN AND METHIONINE - Google Patents

PHARMACEUTICAL COMPOSITION INCLUDING GLP-1 AGONIST, INSULIN AND METHIONINE

Info

Publication number
UA109420C2
UA109420C2 UAA201207165A UAA201207165A UA109420C2 UA 109420 C2 UA109420 C2 UA 109420C2 UA A201207165 A UAA201207165 A UA A201207165A UA A201207165 A UAA201207165 A UA A201207165A UA 109420 C2 UA109420 C2 UA 109420C2
Authority
UA
Ukraine
Prior art keywords
agonist
methionine
insulin
pharmaceutical composition
composition including
Prior art date
Application number
UAA201207165A
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/067250 external-priority patent/WO2011058083A1/en
Publication of UA109420C2 publication Critical patent/UA109420C2/en

Links

Abstract

Винахід стосується рідкої композиції, що включає агоніст GLP-1 (desProексендин-4(1-39)-LyS-NH) і/або його фармакологічно прийнятну сіль, інсулін (Gly(A21)-Arg(B31)-Arg(B32)-iнcyлiн людини) і/або його фармакологічно прийнятну сіль і, необов'язково, щонайменше одну фармацевтично прийнятну допоміжну речовину, де дана композиція містить L-метіонін та має значення pH від 3,5 до 4,5.The invention relates to a liquid composition comprising the GLP-1 agonist (desProexendin-4 (1-39) -LyS-NH) and / or its pharmacologically acceptable salt, insulin (Gly (A21) -Arg (B31) -Arg (B32) - human incyline) and / or its pharmacologically acceptable salt and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition contains L-methionine and has a pH of from 3.5 to 4.5.

UAA201207165A 2009-11-13 2010-11-11 PHARMACEUTICAL COMPOSITION INCLUDING GLP-1 AGONIST, INSULIN AND METHIONINE UA109420C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009052831 2009-11-13
PCT/EP2010/067250 WO2011058083A1 (en) 2009-11-13 2010-11-11 Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine

Publications (1)

Publication Number Publication Date
UA109420C2 true UA109420C2 (en) 2015-08-25

Family

ID=54772073

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201207165A UA109420C2 (en) 2009-11-13 2010-11-11 PHARMACEUTICAL COMPOSITION INCLUDING GLP-1 AGONIST, INSULIN AND METHIONINE

Country Status (1)

Country Link
UA (1) UA109420C2 (en)

Similar Documents

Publication Publication Date Title
ES2534191T3 (en) Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
MY159565A (en) Pharmaceutical composition comprising a glp-1 agonist and methionine
CY1121423T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A METABOLIC SYNDROME
CY1119582T1 (en) HYDRAULIC INSULIN PREPARATIONS CONTAINING Methionine
TN2015000053A1 (en) Fusion proteins for treating a metabolic syndrome
ME02015B (en) Pharmaceutical compositions with (1S)-1,5-anhydro-1-[5- (4-ethoxybenzyl)-2- methoxy-4-methylphenyl]-1-thio-D-glucitol and an insulin secretagogue
MX2010004503A (en) Oxadiazolidinedione compound.
WO2009086400A3 (en) Recombinant vwf formulations
MY149622A (en) Pyrazoles as 11-beta-hsd-1
AR077638A1 (en) COMPOSITE OF (METHANOSULPHONYL -PIPERIDIN) - (ALCOXI-ARIL) -TETRAHIDRO- PYRIDINE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF DIABETES OR OBESITY
PE20080519A1 (en) ISOPROPYL ESTER DERIVATIVES OF 4- [5-METOXY-6- (2-METHYL-6- [1,2,4] TRIAZOL-1-IL-PYRIDIN-3-ILAMINO) PYRIMIDIN-4-ILOXI] -PIPERIDINE- 1-CARBOXYL AND ITS PHARMACEUTICAL COMPOSITIONS
CL2007001873A1 (en) ((3s)) - 6 - ((¨2,6-dimethyl-4- (3- (methylsulfonyl) -propoxy) biphenyl-3-yl) methoxy-2,3-dihydro-1-benzofuran-3-yl acid ) acetic or salt thereof
CL2011003173A1 (en) Glucagon analog, gip and glp-1 agonist; dimer comprising the glucagon analog; conjugated to the analog; composition comprising said analog; use to prepare a medicine to treat diabetes, reduce weight gain, or induce weight loss.
CL2007003440A1 (en) COMPOUNDS DERIVED FROM AZACICLOALCANOS, INHIBITORS FROM ESTEAROIL-COENZIMA TO DELTA-9 DESATURASA; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF DISEASES SUCH AS TYPE 2 DIABETES, INSULIN RESISTANCE, LIPID DISORDERS, OBESIDA
CL2008001125A1 (en) COMPOUNDS DERIVED FROM PIRIMIDINONE CONDENSED WITH HETEROCICLES; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, METABOLIC SYNDROME AND OBESITY.
MA32703B1 (en) COMBINATION OF INSULIN AND GLP AGONIST 1
CL2008001126A1 (en) COMPOUNDS DERIVED FROM PIRIMIDINONE CONDENSED WITH HETEROCICLES; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, METABOLIC SYNDROME AND OBESITY.
CL2007002296A1 (en) COMPOUNDS DERIVED FROM IMIDAZOLINE-2,4-DION SUBSTITUTED WITH ARILAMINOALQUILO; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF METABOLIC SYNDROME, DIABETES, OBESITY, NICOTINE DEPENDENCE, ALCOHOL DEPENDENCE, DISORDER
WO2009111611A3 (en) Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
ATE443722T1 (en) PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE FOR PRODUCING A THERAPEUTIC AND/OR PROPHYLACTICALLY EFFECTIVE PHARMACEUTICAL COMPOSITION
NZ609596A (en) Cyclohexane derivative compound
WO2008116913A3 (en) Peptide compounds with transient biodegradable pegylation
WO2009037586A3 (en) Use of peptidic vasopressin receptor agonists
UA109420C2 (en) PHARMACEUTICAL COMPOSITION INCLUDING GLP-1 AGONIST, INSULIN AND METHIONINE
AR074470A1 (en) AMIDA COMPOUND OF THE CYCLOPROPANOCARBOXYL ACID, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND USE TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF DIABETES